ES8306162A1 - Un procedimiento para la preparacion de glicopeptidos. - Google Patents
Un procedimiento para la preparacion de glicopeptidos.Info
- Publication number
- ES8306162A1 ES8306162A1 ES511516A ES511516A ES8306162A1 ES 8306162 A1 ES8306162 A1 ES 8306162A1 ES 511516 A ES511516 A ES 511516A ES 511516 A ES511516 A ES 511516A ES 8306162 A1 ES8306162 A1 ES 8306162A1
- Authority
- ES
- Spain
- Prior art keywords
- mannopyranosylthio
- metabolizable
- propionyl
- lysine
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE GLICOPEPTIDOS DE FORMULA _[SA N-BN- BA N, DONDE SA ES UN SACARIDO DE 1-4 UNIDADES MONOSACARIDO; B ES UN ESQUELETO Y BRAZO SEPARADOR POLIFUNCIONAL; N VALE 1-4; Y BA ES HIDROGENO O UNA SUSTANCIA BIOLOGICAMENTE ACTIVA. CONSISTE EN LA REACCION DE HIDROLISIS SUAVE DE LOS CORRESPONDIENTES COMPUESTOS EN LOS QUE LOS GRUPOS HIDROXILO DE LOS RADICALES SACARIDOS ESTAN COMPLETAMENTE ACETILADOS. LA HIDROLISIS SE LLEVA A CABO EN LA MEZCLA METANOL-AGUA-TRIETILAMINA 5:4:1, A LA TEMPERATURA AMBIENTE. DESPUES DE EVAPORACION A VACIO SE SEPARA EN UNA COLUMNA DE GEL DE SILICE, ELUYENDO CON CLOROFORMO-METANOL-AGUA. ESTOS COMPUESTOS TIENEN APLICACIONES PARA EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS Y LA ENFERMEDAD DE GAUCHER.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/255,416 US4386026A (en) | 1981-04-20 | 1981-04-20 | Cell-specific glycopeptide ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8306162A1 true ES8306162A1 (es) | 1983-05-01 |
| ES511516A0 ES511516A0 (es) | 1983-05-01 |
Family
ID=22968229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES511516A Granted ES511516A0 (es) | 1981-04-20 | 1982-04-19 | Un procedimiento para la preparacion de glicopeptidos. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4386026A (es) |
| EP (1) | EP0063373B1 (es) |
| JP (1) | JPS57181095A (es) |
| AT (1) | ATE18562T1 (es) |
| DE (1) | DE3269778D1 (es) |
| DK (1) | DK173282A (es) |
| ES (1) | ES511516A0 (es) |
| GR (1) | GR76475B (es) |
| IE (1) | IE52473B1 (es) |
| PT (1) | PT74747B (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4701521A (en) * | 1978-07-17 | 1987-10-20 | The Trustees Of Boston University | Method of effecting cellular uptake of molecules |
| US4466951A (en) * | 1982-11-12 | 1984-08-21 | University Of California | Intracellular trapping of therapeutics or tracer agents |
| FR2551442B1 (fr) * | 1983-09-05 | 1987-04-30 | Centre Nat Rech Scient | Nouveaux derives furaniques, leur preparation et leur application |
| US4873322A (en) * | 1986-01-24 | 1989-10-10 | Ciba-Geigy Corporation | Saccharide derivatives and processes for their manufacture |
| US4946675A (en) * | 1987-05-27 | 1990-08-07 | Xoma Corporation | Hepatic blocking agents |
| US5879680A (en) * | 1987-12-23 | 1999-03-09 | The United States Of America As Represented By The Department Of Health And Human Services | Cloned DNA for synthesizing unique glucocerebrosidase |
| JPH05503691A (ja) * | 1989-12-29 | 1993-06-17 | ユニバーシティ・テクノロジーズ・インターナショナル・インコーポレイテッド | アゴニストおよびアンタゴニストを含む生物学的に活性なリガンドの3次構造モデルの設計方法およびアンギオテンシンに基づいた新規合成アンタゴニスト |
| US5432260A (en) * | 1991-05-03 | 1995-07-11 | Washington University | High affinity mannose receptor ligands |
| US5332575A (en) * | 1991-10-03 | 1994-07-26 | Parfums Christian Dior | Method of targeting melanocytes with a compound containing a fucose residue |
| WO1993025197A1 (en) * | 1992-06-12 | 1993-12-23 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
| TW263437B (es) * | 1992-09-24 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
| US5508387A (en) * | 1993-08-04 | 1996-04-16 | Glycomed Incorporated | Selectin binding glycopeptides |
| CA2173990A1 (en) * | 1993-10-12 | 1995-04-20 | Narasinga Rao | A library of glyco-peptides useful for identification of cell adhesion inhibitors |
| EP0831817B1 (en) * | 1995-06-07 | 2001-03-14 | Joel K. Swadesh | Antigen-processing cell-targeted conjugates comprising a polyamino acid backbone and a non-steroidal anti-inflammatory agent |
| US5965719A (en) * | 1996-11-15 | 1999-10-12 | Sunsorb Biotech, Inc. | Combinatorial synthesis of carbohydrate libraries |
| WO1998031392A1 (en) * | 1997-01-17 | 1998-07-23 | Drug Delivery System Institute, Ltd. | Nephrotropic drugs |
| DE69830305T2 (de) * | 1997-02-20 | 2006-02-02 | Dime, David S., Toronto | Ortsspezifische arzneimittel verabreichung |
| US7033765B1 (en) | 1997-02-20 | 2006-04-25 | Toronto Research Chemicals, Inc. | Site-specific drug delivery |
| DE69834808T2 (de) * | 1997-03-27 | 2007-06-06 | Institut Pasteur | Multiple,kohlenhydrathaltige glycopeptid-antigene, daraus entwickelte impfstoffe sowie deren verwendung |
| AU9258798A (en) * | 1997-08-08 | 1999-03-01 | Hoechst Marion Roussel Deutschland Gmbh | Substituted tetrahydropyrane derivatives, method for producing same, the ir use as medicine or diagnostic agent, as well as medicine containing same |
| ID29943A (id) * | 1998-10-30 | 2001-10-25 | Daiichi Seiyaku Co | Senyawa dds dan metode pengukurannya |
| US6656498B1 (en) | 1998-11-25 | 2003-12-02 | Vanderbilt University | Cationic liposomes for gene transfer |
| US20040058856A1 (en) * | 2000-07-26 | 2004-03-25 | Soo-Young Choi | Oligolysine transducing domain, oligolysine-cargo molecule complex and uses thereof |
| CA2822457C (en) | 2001-12-14 | 2016-03-08 | The University Of Wyoming | Methods and compositions for controlled resease of drugs |
| CN103804458B (zh) * | 2014-02-25 | 2016-08-24 | 中国人民解放军第四军医大学 | 基于胆固醇的三种脂质材料的制备及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3226379A (en) * | 1964-01-14 | 1965-12-28 | Grace W R & Co | Novel 1,3-bis(polyhydroxyalkyl)-2-imidazolidinones and 1,3-bis(polyhydroxyalkyl)-imidazolidine-2-thiones |
| US3859337A (en) * | 1969-06-11 | 1975-01-07 | Stauffer Chemical Co | Ethylenediaminetetraacetic acid anhydride derivatives |
| US3953594A (en) * | 1971-08-13 | 1976-04-27 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Process for preparing bleomycin group antibiotics |
| IT1050366B (it) * | 1972-10-18 | 1981-03-10 | Chinos Ind Farmacobilologica S | Sali di amminoacidi con esteri polisolforici di glicopeptidi naturali e loro preparazione |
| US4195128A (en) * | 1976-05-03 | 1980-03-25 | Bayer Aktiengesellschaft | Polymeric carrier bound ligands |
| SE431758B (sv) * | 1977-03-04 | 1984-02-27 | Pharmacia Fine Chemicals Ab | Som tioleringsreagens eller berarmatris for enzymer anvendbart derivat av en sh-grupphaltig polymer |
| US4120953A (en) * | 1977-04-04 | 1978-10-17 | American Cyanamid Company | Novel 2,2', 2"-[s-phenenyltris(sulfonylimino)tris]-[2-deoxy-α-D-glucopyranose], dodecakis (H-sulfate) compounds and their salts |
| US4241053A (en) * | 1978-08-25 | 1980-12-23 | Tanabe Seiyaku Co., Ltd. | Novel nitrosourea compounds and process for preparing the same |
| US4223013A (en) * | 1978-12-29 | 1980-09-16 | Syva Company | Amitriptyline conjugates to antigenic proteins and enzymes |
| GB2044262B (en) * | 1979-03-05 | 1983-01-26 | Nippon Kayaku Kk | Bleomycin group antibiotics |
| JPS5646897A (en) * | 1979-09-26 | 1981-04-28 | Seiichi Shibata | Novel glycopeptide |
| US4259233A (en) * | 1979-10-23 | 1981-03-31 | Miles Laboratories, Inc. | β-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates |
| CA1203532A (en) * | 1980-07-10 | 1986-04-22 | Chembiomed Ltd. | Synthesis of tumor antigenic determinant |
-
1981
- 1981-04-20 US US06/255,416 patent/US4386026A/en not_active Expired - Fee Related
-
1982
- 1982-04-13 GR GR67908A patent/GR76475B/el unknown
- 1982-04-14 PT PT74747A patent/PT74747B/pt not_active IP Right Cessation
- 1982-04-16 IE IE898/82A patent/IE52473B1/en not_active IP Right Cessation
- 1982-04-19 AT AT82103247T patent/ATE18562T1/de not_active IP Right Cessation
- 1982-04-19 DE DE8282103247T patent/DE3269778D1/de not_active Expired
- 1982-04-19 ES ES511516A patent/ES511516A0/es active Granted
- 1982-04-19 DK DK173282A patent/DK173282A/da active IP Right Grant
- 1982-04-19 EP EP82103247A patent/EP0063373B1/en not_active Expired
- 1982-04-20 JP JP57064870A patent/JPS57181095A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0063373B1 (en) | 1986-03-12 |
| DE3269778D1 (en) | 1986-04-17 |
| DK173282A (da) | 1982-10-21 |
| ATE18562T1 (de) | 1986-03-15 |
| IE52473B1 (en) | 1987-11-11 |
| EP0063373A1 (en) | 1982-10-27 |
| US4386026A (en) | 1983-05-31 |
| GR76475B (es) | 1984-08-10 |
| ES511516A0 (es) | 1983-05-01 |
| PT74747B (en) | 1985-01-08 |
| JPS57181095A (en) | 1982-11-08 |
| IE820898L (en) | 1982-10-20 |
| PT74747A (en) | 1982-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8306162A1 (es) | Un procedimiento para la preparacion de glicopeptidos. | |
| US5597578A (en) | TGF-β protein compositions for inhibition of cell proliferation | |
| AU8123891A (en) | Continuous release pharmaceutical compositions | |
| DE3579068D1 (de) | Arzneimittelenthaltende matrizen fuer einfuehrungen in zonen mit cellularen lesionen. | |
| AU637637B2 (en) | Estrogen-containing active substance plaster | |
| KR20040043113A (ko) | 당뇨병의 치료방법 | |
| IL135835A0 (en) | Novel conjugates of opioids and endogenous carriers | |
| CA2093806A1 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
| HUP0101545A1 (hu) | Peptideket időben elnyújtva kibocsátó gyógyászati készítmények és eljárás az előállításukra | |
| BR9607336A (pt) | Composições de aminoácidos e utilidades das mesmas em nutrição clinica | |
| JP3064417B2 (ja) | 放出制御性製剤及び方法 | |
| KR890000520A (ko) | 폴리펩티드 | |
| Melton et al. | Covalent linkage of carboxypeptidase G2 to soluble dextrans—II: in vivo distribution and fate of conjugates | |
| McGraw et al. | Sucralfate | |
| Guilhou et al. | Somatostatin treatment of psoriasis | |
| AU6587998A (en) | Ligand/lytic peptide compositions and methods of use | |
| Lin et al. | Granule proteins of the dental follicle and stellate reticulum inhibit tooth eruption and eyelid opening in postnatal rats | |
| EP0374532A3 (en) | Improved phase separation-microencapsulated pharmaceutical compositions useful for alleviating dental disease | |
| Duncan et al. | Biological evaluation of soluble synthetic polymers as drug carriers | |
| Shoham et al. | Feedback inhibition of thymic secretory activity in mice treated by the thymic extract TP-1 (thymostimulin) | |
| JPH06293631A (ja) | ケラチン加水分解物を担体として用いたドラッグデリバリーシステム | |
| SU651812A1 (ru) | Способ предупреждени образовани спаек | |
| Younger et al. | Protective effects of ileal bypass versus administration of clofibrate on experimental hypercholesterolemia and atherosclerosis in monkeys | |
| STRATFORD | PERMEATION AND METABOLIC BARRIERS TO THE ABSORPTION AND DISTRIBUTION OF TOPICALLY APPLIED ENKEPHALINS IN THE ALBINO RABBIT EYE. | |
| RU2188032C1 (ru) | Средство, стимулирующее дифференцировку т-лимфоцитов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970401 |